MRE-269

• Target :

  Prostaglandin Receptor

• Related Pathways :

  Immunology/Inflammation|||GPCR/G Protein

• Purity :

  0.9957

• Bioactivity :

  MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 (ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269 (ACT-333679) is an active metabolite of Selexipag (S253150) .

• Smiles :

  N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3

• Molecular Formula :

  C25H29N3O3

• Molecular Weight :

  419.52

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  475085-57-5